Medipharm Labs Corp Stock Buy Hold or Sell Recommendation
| LABS Stock | CAD 0.07 0.01 7.14% |
Assuming the 90 days trading horizon and your way above-average risk tolerance, our recommendation regarding Medipharm Labs Corp is 'Strong Sell'. The recommendation algorithm takes into account all of Medipharm Labs' available fundamental, technical, and predictive indicators you will find on this site.
Check out Medipharm Labs Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Medipharm and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Medipharm Labs Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Medipharm |
Execute Medipharm Labs Buy or Sell Advice
The Medipharm recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Medipharm Labs Corp. Macroaxis does not own or have any residual interests in Medipharm Labs Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Medipharm Labs' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Medipharm Labs Trading Alerts and Improvement Suggestions
| Medipharm Labs Corp had very high historical volatility over the last 90 days | |
| Medipharm Labs Corp has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 33.06 M. Net Loss for the year was (13.08 M) with loss before overhead, payroll, taxes, and interest of (13.42 M). | |
| Medipharm Labs Corp has accumulated about 24.14 M in cash with (11.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: MEDIF Net Income -9.96 Mil - GuruFocus.com |
Medipharm Labs Returns Distribution Density
The distribution of Medipharm Labs' historical returns is an attempt to chart the uncertainty of Medipharm Labs' future price movements. The chart of the probability distribution of Medipharm Labs daily returns describes the distribution of returns around its average expected value. We use Medipharm Labs Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Medipharm Labs returns is essential to provide solid investment advice for Medipharm Labs.
| Mean Return | 0.04 | Value At Risk | -7.14 | Potential Upside | 7.69 | Standard Deviation | 5.60 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Medipharm Labs historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Medipharm Labs Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (42.1M) | 29.4M | 11.2M | (103K) | 3.1M | 3.3M | |
| Investments | (32.5M) | (2K) | 35K | 5.2M | 6.9M | 7.2M | |
| Change In Cash | 30.8M | (18.7M) | 14.2M | (10.0M) | (6.2M) | (5.9M) | |
| Net Borrowings | 6.0M | 3.5M | 22.1M | (3.0M) | (3.4M) | (3.2M) | |
| Free Cash Flow | (57.7M) | (45.3M) | (14.0M) | (16.9M) | (12.2M) | (12.8M) | |
| Depreciation | 2.5M | 10.8M | 5.6M | 2.9M | 2.5M | 3.8M | |
| Other Non Cash Items | 186K | 3.7M | 11.6M | 1.9M | (4.0M) | (3.8M) | |
| Capital Expenditures | 32.4M | 7.5M | 783K | 863K | 471K | 447.5K | |
| Net Income | 1.1M | (67.1M) | (54.8M) | (30.0M) | (13.1M) | (13.7M) | |
| End Period Cash Flow | 38.6M | 19.9M | 34.1M | 24.1M | 18.0M | 20.0M | |
| Change To Netincome | 7.5M | 20.8M | 710K | 14.1M | 16.2M | 8.1M |
Medipharm Labs Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Medipharm Labs or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Medipharm Labs' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Medipharm stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.12 | |
β | Beta against Dow Jones | -0.7 | |
σ | Overall volatility | 5.46 | |
Ir | Information ratio | -0.02 |
Medipharm Labs Volatility Alert
Medipharm Labs Corp exhibits above-average semi-deviation for your current time horizon. Medipharm Labs Corp is a penny stock. Although Medipharm Labs may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Medipharm Labs Corp. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Medipharm instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Medipharm Labs Fundamentals Vs Peers
Comparing Medipharm Labs' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Medipharm Labs' direct or indirect competition across all of the common fundamentals between Medipharm Labs and the related equities. This way, we can detect undervalued stocks with similar characteristics as Medipharm Labs or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Medipharm Labs' fundamental indicators could also be used in its relative valuation, which is a method of valuing Medipharm Labs by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Medipharm Labs to competition |
| Fundamentals | Medipharm Labs | Peer Average |
| Return On Equity | -0.25 | -0.31 |
| Return On Asset | -0.0717 | -0.14 |
| Profit Margin | (0.35) % | (1.27) % |
| Operating Margin | (0.23) % | (5.51) % |
| Current Valuation | 14.28 M | 16.62 B |
| Shares Outstanding | 411.12 M | 571.82 M |
| Shares Owned By Insiders | 4.45 % | 10.09 % |
| Shares Owned By Institutions | 0.71 % | 39.21 % |
| Number Of Shares Shorted | 252.82 K | 4.71 M |
| Price To Earning | 172.00 X | 28.72 X |
| Price To Book | 0.59 X | 9.51 X |
| Price To Sales | 0.71 X | 11.42 X |
| Revenue | 33.06 M | 9.43 B |
| Gross Profit | (13.42 M) | 27.38 B |
| EBITDA | (16.35 M) | 3.9 B |
| Net Income | (13.08 M) | 570.98 M |
| Cash And Equivalents | 24.14 M | 2.7 B |
| Cash Per Share | 0.20 X | 5.01 X |
| Total Debt | 2.29 M | 5.32 B |
| Debt To Equity | 0.14 % | 48.70 % |
| Current Ratio | 3.19 X | 2.16 X |
| Book Value Per Share | 0.13 X | 1.93 K |
| Cash Flow From Operations | (11.76 M) | 971.22 M |
| Short Ratio | 1.31 X | 4.00 X |
| Earnings Per Share | (0.03) X | 3.12 X |
| Target Price | 0.1 | |
| Number Of Employees | 166 | 18.84 K |
| Beta | 0.92 | -0.15 |
| Market Capitalization | 26.72 M | 19.03 B |
| Total Asset | 63.94 M | 29.47 B |
| Retained Earnings | (176.73 M) | 9.33 B |
| Working Capital | 25.77 M | 1.48 B |
| Net Asset | 63.94 M |
Medipharm Labs Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Medipharm . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0714 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 0.0675 | |||
| Day Typical Price | 0.0667 | |||
| Market Facilitation Index | 0.005 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
About Medipharm Labs Buy or Sell Advice
When is the right time to buy or sell Medipharm Labs Corp? Buying financial instruments such as Medipharm Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Medipharm Labs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Investing Thematic Idea Now
Investing
Companies involved in money management and investment banking services. The Investing theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investing Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Medipharm Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.